Valeant Pharma strikes US$250-million friendly deal to buy Solta Medical | iNFOnews | Thompson-Okanagan's News Source
Subscribe

Would you like to subscribe to our newsletter?

Current Conditions Mostly Cloudy  4.9°C

Valeant Pharma strikes US$250-million friendly deal to buy Solta Medical

LAVAL, Que. - Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a friendly deal to acquire Solta Medical, Inc. a California-based company that makes medical devices used in cosmetic surgery procedures.

The Montreal-area company's offer of US$2.92 per share for all of Solta's stock is valued at US$250 million, a 40 per cent premium to Friday's closing price on Nasdaq.

Solta's board of directors supports offer, which requires that Valeant gets at least a majority of Solta's shares.

News from © The Canadian Press, 2013
The Canadian Press

  • Popular kamloops News
View Site in: Desktop | Mobile